MIM
CBIO

MetLife Investment Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

MetLife Investment Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-166
Closed -$198K – 2356
2019
Q2 		$198K Hold
166
– – ﹤0.01% 2027
2019
Q1 		$207K Hold
166
– – ﹤0.01% 1965
2018
Q4 		$158K Hold
166
– – ﹤0.01% 2043
2018
Q3 		$240K Hold
166
– – ﹤0.01% 1982
2018
Q2 		$268K Buy
+166
New +$268K ﹤0.01% 1771